Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Abbvie inc. save search
AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHERE® (mirvetuximab soravtansine-gynx), Expanding Solid Tumor Portfolio
Published: 2023-11-30 (Crawled : 15:30) - biospace.com/
MS 3 d | $86.99 0.93% -0.26% 9.5M
|
Finance
|
| O: 0.28%
H: 0.9%
C: 0.72%
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: -0.35%
H: 3.4%
C: 3.17%
IMGN | $31.23 0.03% 49M
|
Health Technology
|
| O: 81.82%
H: 0.0%
C: 0.0%
elahere abbvie cancer tumor acquire therapy
AbbVie Announces Positive Topline Results from Phase 2 LUMINOSITY Trial Evaluating Telisotuzumab-Vedotin (Teliso-V) for Patients with Previously Treated Non-Small Cell Lung Cancer (NSCLC)
Published: 2023-11-29 (Crawled : 14:30) - biospace.com/
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: -0.73%
H: 0.78%
C: 0.35%
lung abbvie positive cancer cell topline trial results
CollPlant Biotechnologies Announces Third Quarter Financial Results for 2023
Published: 2023-11-29 (Crawled : 12:00) - prnewswire.com
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: -0.73%
H: 0.78%
C: 0.35%
CLGN | $5.245 2.64% 6.5K
|
Health Technology
|
| O: -3.32%
H: 4.15%
C: -3.43%
biotechnologies financial results
Alvotech Reports Financial Results for First Nine Months of 2023 and Provides Business Update
Published: 2023-11-28 (Crawled : 21:00) - globenewswire.com
ALVO | $12.45 1.72% 1.69% 220K
|
n/a
|
| O: 1.02%
H: 0.0%
C: -5.05%
NVS | $94.41 0.95% 0.0% 1.4M
|
Health Technology
|
| O: 0.18%
H: 0.12%
C: -0.16%
JNJ | $147.59 0.05% 0.0% 8.5M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: -0.73%
H: 0.78%
C: 0.35%
KMDA | $5.15 -0.96% -0.97% 16K
|
Health Technology
|
| O: 0.73%
H: 0.0%
C: -1.04%
business update financial results
Alvotech Reports Financial Results for First Nine Months of 2023 and Provides a Business Update
Published: 2023-11-28 (Crawled : 21:00) - globenewswire.com
ALVO | $12.45 1.72% 1.69% 220K
|
n/a
|
| O: 1.02%
H: 0.0%
C: -5.05%
JNJ | $147.59 0.05% 0.0% 8.5M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: -0.73%
H: 0.78%
C: 0.35%
KMDA | $5.15 -0.96% -0.97% 16K
|
Health Technology
|
| O: 0.73%
H: 0.0%
C: -1.04%
business update financial results
Open-Angle Glaucoma Therapeutics Market size to grow by USD 2.36 billion from 2022 to 2027, North America to account for 51% of market growth - Technavio
Published: 2023-11-28 (Crawled : 06:00) - prnewswire.com
NVS | $94.41 0.95% 0.0% 1.4M
|
Health Technology
|
| O: -0.54%
H: 0.08%
C: -0.22%
BHC | $8.63 -1.48% 0.0% 3.2M
|
Health Technology
|
| O: -0.73%
H: 1.17%
C: 0.29%
ALC | $81.09 -0.23% 0.0% 690K
|
Health Technology
|
| O: -0.14%
H: 1.24%
C: 0.53%
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: 0.19%
H: 0.0%
C: 0.0%
america glaucoma therapeutics growth market
AbbVie Announces U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) Updates for Epcoritamab (EPKINLY®/TEPKINLY®) for the Treatment of Relapsed/Refractory Follicular Lymphoma
Published: 2023-11-27 (Crawled : 12:00) - prnewswire.com
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: -0.26%
H: 0.0%
C: 0.0%
epkinly drug abbvie food treatment
Global Pain Management Drugs and Devices Market Report 2023 - Focus on Key Players in Pain Management: Abbott Laboratories, AbbVie, Novartis and More
Published: 2023-11-24 (Crawled : 23:00) - prnewswire.com
ABT | $108.89 -0.2% 0.04% 4.6M
|
Health Technology
| Email alert
Add to watchlist
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
| Email alert
Add to watchlist
JNJ | $147.59 0.05% 0.0% 8.5M
|
Health Technology
| Email alert
Add to watchlist
management report global novartis market
HIV Drugs Market to Reach $51.1 Billion, Globally, by 2032 at 4.5% CAGR: Allied Market Research
Published: 2023-11-17 (Crawled : 16:00) - prnewswire.com
JNJ | $147.59 0.05% 0.0% 8.5M
|
Health Technology
|
| O: 0.78%
H: 0.0%
C: 0.0%
BMY | $48.51 0.48% 0.0% 12M
|
Health Technology
|
| O: 0.69%
H: 0.06%
C: -0.68%
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
GILD | $67.76 -1.3% -1.31% 7.7M
|
Health Technology
|
| O: 0.5%
H: 0.82%
C: 0.75%
reach research hiv market
United States Employment Screening Market Insights Report 2023: A $2+ Billion Industry in 2022 - Forecasts to 2027 - Importance of Social Media Gaining Traction
Published: 2023-11-16 (Crawled : 03:00) - prnewswire.com
AZNCF | $138.88 -4.19% 960
|
Health Technology
|
| O: -2.16%
H: 4.44%
C: 2.2%
TFX | $210.66 -1.76% 0.0% 290K
|
Health Technology
|
| O: 0.9%
H: 1.16%
C: 0.07%
GE | $153.7 -0.6% -0.05% 6.3M
|
Electronic Technology
|
| O: 0.25%
H: 2.03%
C: 2.02%
BDX | $234.72 -0.19% 0.0% 830K
|
Health Technology
|
| O: 0.38%
H: 0.84%
C: 0.18%
BAX | $40.04 -0.72% -0.6% 3M
|
Health Technology
|
| O: -0.06%
H: 0.72%
C: 0.45%
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: 0.28%
H: 0.39%
C: 0.0%
ABT | $108.89 -0.2% 0.04% 4.6M
|
Health Technology
|
| O: 0.5%
H: 0.0%
C: 0.0%
MMM | $91.3 -0.01% 0.31% 3.5M
|
Producer Manufacturing
|
| O: -0.96%
H: 0.58%
C: -0.19%
ICUI | $97.215 -1.0% -1.01% 210K
|
Health Technology
|
| O: -0.24%
H: 0.69%
C: -1.33%
AZN | $68.75 -0.26% -0.26% 7.6M
|
Health Technology
|
| O: 0.46%
H: 0.71%
C: 0.6%
media report market
Precision Medicine Market size to grow by 54.7 billion from 2022 to 2027- Technavio
Published: 2023-11-14 (Crawled : 23:00) - prnewswire.com
SNYNF | $92.9 -2.18% 880
|
Health Technology
|
| O: -1.44%
H: 0.0%
C: -0.84%
AZNCF | $138.88 -4.19% 960
|
Health Technology
|
| O: -0.32%
H: 1.79%
C: -0.19%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -2.21%
H: 0.0%
C: -0.32%
TMO | $557.87 -1.3% 0.0% 1M
|
Health Technology
|
| O: 1.67%
H: 0.0%
C: 0.0%
NVS | $94.41 0.95% 0.0% 1.4M
|
Health Technology
|
| O: -0.57%
H: 0.37%
C: -0.6%
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: -0.74%
H: 0.0%
C: 0.0%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: -0.72%
H: 0.0%
C: 0.0%
AZN | $68.75 -0.26% -0.26% 7.6M
|
Health Technology
|
| O: -1.15%
H: 0.43%
C: -0.57%
market
Opioid Market Forecast: In-depth Analysis Predicts Continued Growth to $25.3 Billion by 2030
Published: 2023-11-14 (Crawled : 02:00) - prnewswire.com
JNJ | $147.59 0.05% 0.0% 8.5M
|
Health Technology
|
| O: 0.17%
H: 0.0%
C: 0.0%
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: 0.47%
H: 0.0%
C: 0.0%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: 0.68%
H: 0.0%
C: 0.0%
opioid growth market
Global Pharmaceutical Contract Manufacturing Market Report 2023-2030 with Competitive Analysis of Major Players - Overview, Financials, Product Portfolio, Key Developments, Business Strategy, SWOT
Published: 2023-11-14 (Crawled : 01:00) - prnewswire.com
TMO | $557.87 -1.3% 0.0% 1M
|
Health Technology
|
| O: 2.48%
H: 0.0%
C: 0.0%
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: 0.47%
H: 0.0%
C: 0.0%
report business contract global market
NEXGEL Reports Record Third Quarter 2023 Revenue of $1.2 Million, an Increase of 115% Year-Over-Year
Published: 2023-11-13 (Crawled : 21:00) - globenewswire.com
NXGL | $2.18 0.47% 1.4K
|
Manufacturing
|
| O: 7.39%
H: 1.06%
C: -5.29%
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: 0.47%
H: 0.0%
C: 0.0%
revenue
Oncology Drugs Market worth $520 billion by 2033 - Exclusive Report by We Market Research
Published: 2023-11-10 (Crawled : 15:00) - prnewswire.com
AZNCF | $138.88 -4.19% 960
|
Health Technology
|
| O: 0.1%
H: 0.0%
C: -2.14%
ALPMY | $9.55 -1.11% 300K
|
Manufacturing
|
| O: -3.48%
H: 3.87%
C: 3.61%
PFE A | $25.91 0.19% -0.04% 34M
|
Health Technology
|
| O: 0.24%
H: 0.22%
C: -0.91%
JNJ | $147.59 0.05% 0.0% 8.5M
|
Health Technology
|
| O: -1.24%
H: 0.0%
C: 0.0%
BMY | $48.51 0.48% 0.0% 12M
|
Health Technology
|
| O: 0.4%
H: 0.18%
C: 0.0%
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: 0.44%
H: 0.0%
C: 0.0%
AZN | $68.75 -0.26% -0.26% 7.6M
|
Health Technology
|
| O: -1.33%
H: 0.22%
C: -0.11%
report research market
Mexico aesthetic devices market to grow by USD 533.06 million from 2023 to 2028- Technavio
Published: 2023-11-09 (Crawled : 23:00) - prnewswire.com
BHC | $8.63 -1.48% 0.0% 3.2M
|
Health Technology
|
| O: 0.29%
H: 0.15%
C: -0.73%
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: 0.44%
H: 0.0%
C: 0.0%
INMD | $17.685 -1.31% -1.33% 2.2M
|
Health Technology
|
| O: 0.2%
H: 0.18%
C: -1.17%
aesthetic market
Trishula Therapeutics Initiates Phase 2 Trial of TTX-030, an Anti-CD39 Antibody, in First Line Metastatic Pancreatic Cancer Patients
Published: 2023-11-09 (Crawled : 14:00) - biospace.com/
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: -1.81%
H: 0.43%
C: -2.1%
ttx-030 cancer pancreatic trial therapeutics phase 2
Ironwood Pharmaceuticals Reports Third Quarter 2023 Results
Published: 2023-11-09 (Crawled : 13:30) - biospace.com/
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: -1.81%
H: 0.43%
C: -2.1%
IRWD | $7.795 -1.08% -1.09% 2.5M
|
Health Technology
|
| O: 2.93%
H: 4.37%
C: 0.21%
pharmaceuticals ironwood results
Advanced Anesthesia Devices and Ambulatory Surgical Centers Propel Growth in the US Anesthesia Market
Published: 2023-11-07 (Crawled : 00:00) - prnewswire.com
AZNCF | $138.88 -4.19% 960
|
Health Technology
|
| O: -1.99%
H: 1.92%
C: 1.89%
TFX | $210.66 -1.76% 0.0% 290K
|
Health Technology
|
| O: 0.92%
H: 0.39%
C: -3.0%
KKR | $95.84 -1.49% -0.77% 3.3M
|
Finance
|
| O: 0.43%
H: 0.28%
C: -0.32%
GE | $153.7 -0.6% -0.05% 6.3M
|
Electronic Technology
|
| O: 0.36%
H: 1.65%
C: 1.47%
BDX | $234.72 -0.19% 0.0% 830K
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: -0.64%
BAX | $40.04 -0.72% -0.6% 3M
|
Health Technology
|
| O: 0.73%
H: 0.0%
C: -1.19%
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: 1.55%
H: 0.0%
C: 0.0%
ABT | $108.89 -0.2% 0.04% 4.6M
|
Health Technology
|
| O: 0.04%
H: 0.54%
C: -0.5%
MMM | $91.3 -0.01% 0.31% 3.5M
|
Producer Manufacturing
|
| O: 0.27%
H: 0.0%
C: -1.16%
ICUI | $97.215 -1.0% -1.01% 210K
|
Health Technology
|
| O: -1.4%
H: 4.7%
C: 4.21%
AZN | $68.75 -0.26% -0.26% 7.6M
|
Health Technology
|
| O: 0.25%
H: 0.64%
C: -0.38%
propel growth market
Genmab Announces Financial Results for the First Nine Months of 2023
Published: 2023-11-07 (Crawled : 16:00) - globenewswire.com
GNMSF | $291.12 3.83% 300
|
Health Technology
|
| O: 0.39%
H: 4.92%
C: 1.52%
NVS | $94.41 0.95% 0.0% 1.4M
|
Health Technology
|
| O: 0.24%
H: 0.18%
C: 0.16%
JNJ | $147.59 0.05% 0.0% 8.5M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
ABBV | $161.67 -0.38% -0.04% 5.4M
|
Health Technology
|
| O: -0.28%
H: 0.0%
C: 0.0%
GMAB | $29.51 0.85% 0.85% 500K
|
Health Technology
|
| O: 0.24%
H: 3.44%
C: 2.07%
BNTX | $87.88 1.62% 1.59% 750K
|
Health Technology
|
| O: -0.35%
H: 3.09%
C: 3.03%
financial results
Gainers vs Losers
| 49% | 51% |
Top 10 Gainers
KAVL | $6.275 135.02% 57.45% 44M
|
Wholesale Trade
PXMD | $0.7375 79.09% 44.16% 4.5M
|
Health Technology
DYNT | $0.371 -5.12% 43.09% 3.3M
|
Health Technology
LGVN P 3 d | $2.94 73.96% 42.52% 57M
|
HUBC | $1.94 49.23% 32.99% 73M
|
n/a
SPCB | $0.4044 46.52% 31.75% 130M
|
Electronic Technology
ONVO | $1.34 32.66% 24.62% 54M
|
Health Technology
OMQS | $0.6869 32.1% 24.3% 3.6M
|
Professional, Scientific, and T...
SNPO | $10.555 29.67% 22.88% 4M
|
AMBI | $3.72 -26.77% 21.77% 9.8K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.